Europe
Bayer Plc launches LifeHub UK as part of a global network of Bayer global innovation hubs. LifeHub UK is designed to accelerate and optimise disease detection and data-driven drug discovery by developing Artificial Intelligence (AI)-enabled imaging solutions.
Expands on existing collaboration agreement with Bayer to accelerate the development of new treatments for cardiovascular disease using clinical AI
Heidelberg Pharma AG reported on the first nine months of fiscal year 2019 and the Group’s financial figures.
PetaGene today announced that Princess Máxima Center for Pediatric Oncology, the largest pediatric cancer center in Europe, has chosen to use PetaGene’s transparent, lossless genomic data compression software, called PetaSuite, to reduce its data storage costs while accelerating access to the data.
The U.S. Food and Drug Administration approved Janssen Pharmaceutical’s Xarelto for the prevention of venous thromboembolism, or blood clots, in acutely sick patients in hospitals who are at risk for blood clots but who are not at high risk of bleeding.
Roche announced results from its Phase III PEMPHIX trial evaluated MabThera/Rituxan (rituximab) compared to mycophenolate mofetil (MMF) in adults with moderate to severe pemphigus vulgaris.
It was a busy week for clinical trial announcements. Here’s a look.
Aleph Farms announced last week they 3D printed a small piece of muscle tissue on the International Space Station. The success of this miniature steak highlights the key advantage of cultivated meat: you can make it anywhere.
As Gilead Sciences and its development partner Galapagos NV eye filing a New Drug Application with the U.S. Food and Drug Administration for its JAK inhibitor filgotinib, the companies’ hopes have been boosted by new 52-week safety data.
Roche Vice Chairman Andre Hoffman is warning that short-term thinking is killing the planet and that corporations must engage in long-term sustainable strategies that limit any environmental harm and can help reverse some of the damage that’s already been done.
PRESS RELEASES